HomeInsightsStock Comparison

Bharat Immunological Biological Corporation Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Bharat Immunological Biological Corporation Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Last Updated on: Aug 08, 2025

Key Highlights

  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 21.8 as of 08 Aug 10:45.
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shree Ganesh Biotech India Ltd changed from 1085 on March 2020 to 52.5 on March 2024 . This represents a CAGR of -45.43% over 5 years.
  • The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 25.13 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Shree Ganesh Biotech India Ltd changed from ₹ 259.5 crore on March 2020 to ₹ 41.86 crore on March 2024 . This represents a CAGR of -30.57% over 5 years.
  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Ganesh Biotech India Ltd for the Jun '25 is ₹ 1.8 crore as compare to the Mar '25 revenue of ₹ 3.47 crore. This represent the decline of -48.13%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Ganesh Biotech India Ltd for the Jun '25 is ₹ 0.33 crore as compare to the Mar '25 ebitda of ₹ -0.95 crore. This represent the decline of -134%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ -4.59 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Shree Ganesh Biotech India Ltd changed from ₹ 0.15 crore to ₹ 0.33 crore over 9 quarters. This represents a CAGR of 41.97% .
  • The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Biotech India Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Shree Ganesh Biotech India Ltd

  • Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' under the Registrar of Companies, West Bengal.
  • The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal.
  • The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
  • The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Fl...

Read more

08 Jan 2025 14:45

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

Shree Ganesh Biotech India Ltd News Hub

News

Shree Ganesh Biotech India to conduct board meeting

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

17 Jul 2025 10:12

News

Shree Ganesh Biotech India to convene board meeting

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

13 May 2025 12:01

News

Shree Ganesh Biotech India to discuss results

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

21 Jan 2025 10:34

News

Shree Ganesh Biotech India announces board meeting date

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on...

Read more

17 Oct 2024 10:28

News

Shree Ganesh Biotech India to convene AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company ...

Read more

16 Sep 2024 10:34

News

Shree Ganesh Biotech India to conduct AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company ...

Read more

14 Sep 2024 17:42

SWOT Analysis Of Shree Ganesh Biotech India Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Shree Ganesh Biotech India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Shree Ganesh Biotech India Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 93 Cr while Market cap of Shree Ganesh Biotech India Ltd is 31 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd?

As of August 8, 2025, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹21.63. On the other hand, Shree Ganesh Biotech India Ltd stock price is INR ₹0.79.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Shree Ganesh Biotech India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions